Roberts Glore & CO Inc Vertex Pharmaceuticals Inc Transaction History

Roberts Glore & CO Inc

$341 Million
Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 4,155 shares of VRTX stock, worth $1.93 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

4,155

Previous 4,342 4.31%

Holding current value

$1.93 Million

Previous $2.04 Million 5.06%

% of portfolio

0.57%

Previous 0.62%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $86,020 - $94,580	-187 Reduced 4.31%	4,155 $1.93 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $95,452 - $117,983	-243 Reduced 5.3%	4,342 $2.04 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $110,891 - $121,333	-272 Reduced 5.6%	4,585 $1.92 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $96,383 - $115,401	-281 Reduced 5.47%	4,857 $1.98 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $4,734 - $5,074	-14 Reduced 0.27%	5,138 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $10,375 - $11,613	-33 Reduced 0.64%	5,152 $1.81 Million
Q1 2023 May 08, 2023	SELL	$283.23 - $323.1 $8,213 - $9,369	-29 Reduced 0.56%	5,185 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $94,872 - $106,731	-332 Reduced 5.99%	5,214 $1.51 Million
Q3 2022 Nov 07, 2022	SELL	$273.83 - $305.53 $28,752 - $32,080	-105 Reduced 1.86%	5,546 $1.61 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $91,634 - $114,094	-390 Reduced 6.46%	5,651 $1.59 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $68,325 - $86,251	386 Added 6.83%	6,041 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $1.03 Million - $1.15 Million	5,655 New	5,655 $1.03 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Vertex Pharmaceuticals Inc Transaction History